Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 527 | 691 | 512 | 497 | 403 |
| Gross Profit | 527 | 691 | 512 | 497 | 403 |
| Operating Expenses | 10,170 | 8,726 | 9,347 | 8,047 | 8,327 |
| Operating Income | -9,643 | -8,035 | -8,835 | -7,550 | -7,924 |
| Other Income | 683 | 689 | 575 | 299 | 80 |
| Pre-tax Income | -8,960 | -7,346 | -8,260 | -7,251 | -7,844 |
| Income Tax | -29 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -8,931 | -7,346 | -8,247 | -7,251 | -7,844 |
| Net Income | $-8,931 | $-7,346 | $-8,247 | $-7,251 | $-7,844 |
| EPS Basic Total Ops | -1.09 | -0.89 | -0.99 | -0.86 | -0.94 |
| EPS Basic Continuous Ops | -1.09 | -0.89 | -0.98 | -0.86 | -0.94 |
| EPS Diluted Total Ops | -1.09 | -0.89 | -0.99 | -0.86 | -0.94 |
| EPS Diluted Continuous Ops | -1.09 | -0.89 | -0.98 | -0.86 | -0.94 |
| EPS Diluted Before Non-Recurring Items | -1.09 | -0.89 | -0.98 | N/A | N/A |
| EBITDA(a) | $-9,634 | $-8,026 | $-8,800 | $-7,546 | $-7,926 |